Market Talk
The world has been crippled
by Covid 19 pandemic for
months now. For this reason,
I am focused on a few
companies that may yet be
undervalued. At this time
there is both hype and what
appears to be sound science
to try to discern.
Stock Talk
Yesterday, President Trump hinted that he thinks there will be an unexpected big surprise coming on a vaccine. Each individual company responded to the dynamics at play for each. I still believe the known facts on Inovio Pharmaceuticals (INO) that resulted in neutralizing antibodies and T- cells in another corona virus, mers, provides at least "a dot" that may be forming to show success of INO 4800, their Covid 19 vaccine candidate. Also "a dot" on animal studies in guinea pigs and mice on INO 4800. Results of the Phase 1 trial will tell the rest of the story, where dots will either be confirmed or not. Today, the Stifel analyst, gave opinion that he believed the INO price was no longer palatable, as a buy at the surged prices into the 30's. But he left the target price of $24 a share as a hold. I can partially see the Stifel analyst's point until "we know" what the Phase 1 results are. However, some who believe they can see the future dots forming may disagree. The market is a funny thing. FOMO - Fear of Missing Out
is a dynamic that is sometimes hard to predict and its often too late for some who hesitate in "some". Yesterday and today, a penny stock, Vaxart Inc, surged from single digits to more than double and surged past the 10 range. I saw this happening yesterday and jumped in the $ 5's with "a some" 200 shares as a trade. After a quick look to see the story is about Vaxart collaboration on an oral based vaccine, I decided to continue to think of it as a quick trade and sold my 200 shares this morning in the 11's. A quick double as the Stifel opinion on INO took some steam out of shares, but since recovering quite well. yep, FOMO. Regarding Oral based vaccines, it once was used for the ailment, polio. However, a quick google shows that practice was scrapped in the US and only injections are used for Polio. Without being an expert, I am doubtful Covid 19 neutralizing antibodies will be durable or garnered from an Oral vaccine. I am doubtful that any Oral vaccine candidate will be made and tested in time. why? Two words: "stomach acid". With that view,I took the quick trade gain on Vaxart and hold Inovio. I am holding INO and waiting on the Phase 1 clinical results and will watch "the dots" form along the way. One final point that is being missed by fancy pants analysts: What If INO 4800 succeeds? Then Inovio proves they can "crack the code" and- quick! - on future Corona mutations, pandemics and such deadly pathogens that may suddenly pop up and cripple the world again! Another Inovio "dot"? Oh my indeed. __
ALL in my humble opinion.
This site does NOT make Buy / Sell recommendations.
___
